Literature DB >> 10837640

Controlling liposome blood clearance by surface-grafted polymers.

.   

Abstract

The incorporation of polymer-lipid conjugates, initially using PEG and subsequently other selected flexible, hydrophilic polymers, into lipid bilayers gives rise to sterically stabilized liposomes that exhibit reduced blood clearance and concomitant changes in tissue distribution largely because of reduced, but not eliminated, phagocytic uptake. Changes in tissue distribution includes 'passive' targeting localization into sites of tumors, infection, inflammation characterized by presence of a 'leaky' vasculature which represent useful applications for drug delivery. The polymer forms a surface coating which has been characterized by physical measurements and it appears to function through steric inhibition of the protein binding and cellular interactions leading to phagocytic uptake. The current understanding of the physical and biological properties are reviewed. Ongoing work in the field involves interests to increase complexity such as addition of (1) selective targeting ligands by chemical conjugation to the exterior surface of the polymer coating, (2) capabilities for intracellular release of encapsulated agents into the cytoplasm, and (3) both simultaneously.

Entities:  

Year:  1998        PMID: 10837640     DOI: 10.1016/s0169-409x(97)00136-1

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  35 in total

1.  Evaluation of photochemically immobilized poly(2-ethyl-2-oxazoline) thin films as protein-resistant surfaces.

Authors:  Hui Wang; Liling Li; Qi Tong; Mingdi Yan
Journal:  ACS Appl Mater Interfaces       Date:  2011-08-24       Impact factor: 9.229

2.  Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications.

Authors:  Luc Wasungu; Marco Scarzello; Gooitzen van Dam; Grietje Molema; Anno Wagenaar; Jan B F N Engberts; Dick Hoekstra
Journal:  J Mol Med (Berl)       Date:  2006-06-08       Impact factor: 4.599

Review 3.  Advances in the use of tocols as drug delivery vehicles.

Authors:  Panayiotis P Constantinides; Jihong Han; Stanley S Davis
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

4.  Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.

Authors:  Steven K Libutti; Giulio F Paciotti; Adriana A Byrnes; H Richard Alexander; William E Gannon; Melissa Walker; Geoffrey D Seidel; Nargiza Yuldasheva; Lawrence Tamarkin
Journal:  Clin Cancer Res       Date:  2010-09-27       Impact factor: 12.531

5.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

6.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection.

Authors:  Dissaya Pornpattananangkul; Li Zhang; Sage Olson; Santosh Aryal; Marygorret Obonyo; Kenneth Vecchio; Chun-Ming Huang; Liangfang Zhang
Journal:  J Am Chem Soc       Date:  2011-02-23       Impact factor: 15.419

Review 7.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

8.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

9.  Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.

Authors:  Cédric Chauvierre; Denis Labarre; Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice.

Authors:  Klaus Kunath; Anke von Harpe; Holger Petersen; Dagmar Fischer; Karlheinz Voigt; Thomas Kissel; Ulrich Bickel
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.